These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33824462)

  • 21. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.
    Carder PJ; Shaaban A; Alizadeh Y; Kumarasuwamy V; Liston JC; Sharma N
    Histopathology; 2010 Sep; 57(3):472-8. PubMed ID: 20727019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted?
    Karimi Z; Phillips J; Brook A; Baker G; Guzman Y; Mehta TS
    Acad Radiol; 2022 Jul; 29(7):1029-1038. PubMed ID: 34702673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
    Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
    Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
    Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
    Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
    Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
    Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ.
    Blanco LZ; Thurow TA; Mahajan A; Susnik B; Helenowski I; Chmiel JS; Sullivan ME
    Am J Clin Pathol; 2015 Nov; 144(5):722-6. PubMed ID: 26486735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
    Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
    Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
    Lee J; Ku GY; Lee H; Park HS; Ku JS; Kim JY; Park S; Park BW
    Cancer Res Treat; 2022 Oct; 54(4):1074-1080. PubMed ID: 34942684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
    Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
    Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
    Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
    AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
    [No Abstract]   [Full Text] [Related]  

  • 34. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.
    Harrison BT; Nakhlis F; Dillon DA; Soong TR; Garcia EP; Schnitt SJ; King TA
    Mod Pathol; 2020 Jul; 33(7):1287-1297. PubMed ID: 31932682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobular Carcinoma In Situ.
    Wen HY; Brogi E
    Surg Pathol Clin; 2018 Mar; 11(1):123-145. PubMed ID: 29413653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
    Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
    AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
    Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
    Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation.
    Matar R; Sevilimedu V; Park A; King TA; Pilewskie M
    Ann Surg Oncol; 2022 Mar; 29(3):1670-1679. PubMed ID: 34671879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target.
    D'Alfonso TM; Wang K; Chiu YL; Shin SJ
    Arch Pathol Lab Med; 2013 Jul; 137(7):927-35. PubMed ID: 23808465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.
    Pareja F; Corben AD; Brennan SB; Murray MP; Bowser ZL; Jakate K; Sebastiano C; Morrow M; Morris EA; Brogi E
    Cancer; 2016 Sep; 122(18):2819-27. PubMed ID: 27315013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.